EMN09

Title

Carfilzomib in Combination with Bendamustine and dexamethasone in Refractory or Relapsed Multiple Myeloma

Overview / Summary

Study details

Patient eligibility criteria

Relapsed or refractory multiple myeloma after failure of two or more treatment regimens.

Publications

No publications connected to this trial at the moment